Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of “eye stroke” (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side effect reports published in the British Journal of Ophthalmology.
Source link
Wegovy may have highest 'eye stroke' and sight loss risk among semaglutide GLP-1 agonists
March 10, 2026
0 Comments
Explore More
Lab-grown retinal cells show promise for new eye therapies
Biomedical engineers at Duke University have used induced pluripotent stem cells (iPSCs) to grow specialized blood vessel cells critical to retinal health for the first time. When injected into mouse
Binocular vision is crucial for assessing threats and effective survival, mouse study suggests
Credit: Current Biology (2025). DOI: 10.1016/j.cub.2025.01.066 Having two eyes is crucial to escaping danger, according to a new study conducted by an international team of researchers. The research, published in
mRNA vaccine shows promise for treating age-related macular degeneration
Researchers at Science Tokyo developed an mRNA vaccine that suppressed abnormal retinal blood vessel growth in mouse models. The vaccine can be administered intramuscularly and showed effectiveness comparable to current